Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.
Saved in:
| Title: | Clinical implications and biomarkers in the PACT-21 CASSANDRA trial. |
|---|---|
| Authors: | Neoptolemos JP; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany. Electronic address: john.neoptolemos@med.uni-heidelberg.de., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Öhlund D; Department of Diagnostics and Intervention Oncology, and Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden., Hammel P; Digestive and Medical Oncology, Hôpital Paul Brousse, Villejuif, France., Palmer DH; Cancer Research UK Liverpool Experimental Cancer Medicine Centre, University of Liverpool, Liverpool, UK. |
| Source: | Lancet (London, England) [Lancet] 2026 May 02; Vol. 407 (10540), pp. 1684-1685. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
